Literature DB >> 7061863

Structural and functional characterization of an incompletely processed form of murine C4 and Slp.

D R Karp, J D Capra, J P Atkinson, D C Shreffler.   

Abstract

The properties of a 128,000-dalton polypeptide, corresponding to the uncleaved alpha- and gamma- chains of the fourth component of murine complement (C4), were studied. A fragment of similar size (137,000 daltons) from the structurally related sex-limited protein (Slp) was also found. These polypeptides have methylamine and iodoacetamide binding sites. suggesting that they, like the alpha-chains of C4 and Slp, possess an internal thiolester. In tryptic peptide map analysis, extensive homology is seen between the 128,000-dalton fragment and native C4 alpha- and gamma-chains. N-terminal sequences for this fragment and C4 alpha are identical, as are those for the 137,000-dalton Slp fragment and Slp alpha. Although the alpha-gamma fragment, like C4 alpha, undergoes denaturation-dependent autolytic cleavage, unlike C4 alpha, it cannot be cleaved by C1 This indicate that some of the properties of C4 do not require the native three-chain structure, whereas others do require it. These findings suggest that the alpha-gamma fragments represent an intermediate step in the processing of the C4 and Slp precursor polypeptides.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061863

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Mutants of complement component C3 cleaved by the C4-specific C1-s protease.

Authors:  P Mathias; C J Carrillo; N E Zepf; N R Cooper; R T Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter.

Authors:  Y Miyagoe; E Georgatsou; N Varin-Blank; T Meo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

Review 3.  H-2 S region determined polymorphic variants of the C4, Slp, C2, and B complement proteins: a compilation.

Authors:  J P Atkinson; D R Karp; E P Seeskin; C C Killion; P A Rosa; S L Newell; D C Shreffler
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  S region genetic control of murine C4 biosynthesis: analysis of pro-C4 cleavage.

Authors:  D R Karp; D C Shreffler
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Identification and partial characterization of the secreted form of the fourth component of human complement: evidence that it is different from major plasma form.

Authors:  A C Chan; K R Mitchell; T W Munns; D R Karp; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  Amino acid sequence homologies and glycosylation differences between the fourth component of murine complement and sex-limited protein.

Authors:  D R Karp; K L Parker; D C Shreffler; C Slaughter; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

7.  Characterization of the Mr difference between secreted murine fourth component of complement and the major plasma form: evidence for carboxyl-terminal cleavage of the alpha chain.

Authors:  D R Karp; D C Shreffler; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Complete cDNA sequence of the fourth component of murine complement.

Authors:  D S Sepich; D J Noonan; R T Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Murine complement component C4 and sex-limited protein: identification of amino acid residues essential for C4 function.

Authors:  R T Ogata; N R Cooper; B M Bradt; P Mathias; M A Picchi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Identification and structural characterization of two incompletely processed forms of the fourth component of human complement.

Authors:  A C Chan; J P Atkinson
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.